The Crown corporation behind Canada’s proposed high-speed rail line has released new details on how it plans to expropriate and compensate landowners to carry out the multibillion-dollar project. The ...

After nearly 15 years as Apple CEO, Tim Cook is stepping down. He will continue to operate in the role until Sept. 1, when he will be replaced by John Ternus, the company's senior vice president of ...

Tim Cook will step down as Apple's CEO later this year and be replaced by John Ternus, a senior vice president of hardware engineering, the technology company announced on Monday. Cook will become ...

Apple’s Tim Cook and John Ternus held an all-hands meeting with employees today in Steve Jobs Theater at Apple Park, according to Bloomberg. The meeting comes one day after the announcement that ...

Tim Cook is stepping down from his role as CEO of Apple. In a letter posted publicly on Monday, Cook said Apple will have a new leader starting in September. "I will be transitioning into a new role, ...

Tim Cook, the executive who led Apple to become a $4 trillion company and defined its identity in the post-Steve Jobs era, is stepping down as CEO, Apple said on Monday. John Ternus, Apple’s senior ...

Alto Ingredients has transitioned from a pure ethanol producer to a diversified, higher-margin specialty ingredients and CO₂ business. Q3 results confirm a structural earnings inflection, with GAAP ...

Our team tests, rates, and reviews more than 1,500 products each year to help you make better buying decisions and get more from technology. I have been a technology journalist for 30-plus years and ...

The Illinois-based company’s third-quarter results are: MetricQ3 2025Q3 2024Net Income$13.9 million-$2.8 millionEarnings Per Share (EPS)$0.19-$0.04Gross Profit$23.5 million$6.0 millionAdjusted ...

With Alto Enoteca, the tiny new Italian restaurant on Old Northern Boulevard in Roslyn, Nico Di Lullo is back where he grew up. Well, not literally. His parents, Franco and Gemma Di Lullo, settled in ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...